Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 5 de 5
Filtrer
Plus de filtres










Base de données
Gamme d'année
1.
J Phys Condens Matter ; 24(25): 255403, 2012 Jun 27.
Article de Anglais | MEDLINE | ID: mdl-22647673

RÉSUMÉ

The dynamic mechanical properties of quartz have been studied as a function of temperature across the α-ß phase transition and in the vicinity of the incommensurate (IC) phase on cooling from the ß phase. The mechanical response of the IC phase shows strong anelasticity for measurement of Young's modulus (closely related to C(11) in our geometry) with modulated stress driven at 1 Hz. The dynamic shear modulus does not show similar strong effects in its imaginary component, although a very weak anomaly is barely detectable in the real part of the modulus. Our results indicate that the incommensurate microstructures within the quartz transition interval are susceptible to dilatational stress with relaxation times around 1 s.

2.
J Phys Condens Matter ; 23(42): 425401, 2011 Oct 26.
Article de Anglais | MEDLINE | ID: mdl-21970863

RÉSUMÉ

Calcium stannate perovskite (CaSnO(3)) has been studied by Raman spectroscopy at two excitation wavelengths (514.5 and 632.8 nm). No phase transition was observed. Rather, the thermal evolution of the Raman lines showed a high degree of harmonicity with small Grüneisen parameters and thermal line broadening following Γ=Acothθ/T, where the quantum temperature θ is determined by the phonon branch without further coupling with other degrees of freedom. The geometrical nature of phonon lines has been identified. High-temperature powder x-ray diffraction measurements provide thermal expansion coefficients of α(x)=13.9 × 10(-6) K(-1), α(y)=2.7 × 10(-6) K(-1), α(z)=14.3 × 10(-6) K(-1). The strongly quasi-harmonic behaviour observed and the lack of any indication of instability with respect to the post-perovskite structure points to the strongly first-order character of the reported perovskite to post-perovskite phase transition in this material, which appears to behave as a very good analogue to MgSiO(3) in the Earth's interior.

3.
J Phys Condens Matter ; 22(9): 095901, 2010 Mar 10.
Article de Anglais | MEDLINE | ID: mdl-21389426

RÉSUMÉ

Strontium stannate is under study as an ultra-stable dielectric material for microelectronic applications at low temperatures. It is known to have a remarkably temperature-independent dielectric constant from 27 K to room temperature. However, we report anomalies in the Raman spectra, dielectric response, and differential thermal analysis of strontium stannate compatible with a structural phase transition at 160 K. Further anomalies are seen in calorimetric and Raman data (but not dielectric data) that suggest another phase transition at 270 K. A preliminary x-ray powder diffraction study confirms a small change in the pseudo-cubic lattice constant a(T) at the lower transition.

4.
Phys Rev Lett ; 97(17): 177601, 2006 Oct 27.
Article de Anglais | MEDLINE | ID: mdl-17155506

RÉSUMÉ

We show that lead zirconate titanate thin films undergo local phase decomposition during fatigue. The original remanent polarization of the fatigued film is completely restored after furnace annealing in an O2 atmosphere, following a significant regrowth of a perovskite phase from the pyrochlorelike structure. By comparing our data with other researchers' work on annealing of fatigued ferroelectric samples, we conclude that local phase separation is the generic reason for electrical fatigue in ferroelectrics. A fatigue model is proposed in order to interpret our experimental data.

5.
J Cardiovasc Pharmacol ; 26(5): 777-83, 1995 Nov.
Article de Anglais | MEDLINE | ID: mdl-8637193

RÉSUMÉ

Pure vasodilator drugs are currently the preferred agents for treatment of acute and chronic heart failure of all grades of severity. In contrast, the role of drugs that combine vasodilation with inotropic action remains highly controversial despite their several advantageous physiological actions and long therapeutic history in heart failure. We hypothesize that this uncertainty might be due first to subtle unfavorable hemodynamic effects not detectable by the relatively crude hemodynamic methods by which these agents are usually analyzed, particularly with regard to the quantification of afterload, and secondly to the narrow therapeutic range of these drugs, such that the dose administered is critical. We tested this hypothesis by comparing several refined hemodynamic measurements of dopexamine, an inotropic vasodilator, with a pure arteriovenous dilator (sodium nitroprusside, SNP) on left ventricular (LV) systolic and diastolic function, large arterial behavior, and coupling of the left ventricle to the arterial system at two dose levels in 35 patients with ischemic heart disease. The study protocol was a fixed order of 15-min infusions of saline, dopexamine 1 microg/kg/min, and dopexamine 3 + ++microg/kg/min, or saline, SNP 1 microg/kg/min, and SNP 3 microg/kg/min. Detailed hemodynamic observations were made at the end of each 15-min infusion period. Both drugs produced equivalent arterial vasodilation, as measured by the decrease in systemic vascular resistance index (SVRI), but dopexamine resulted in a significantly greater increase in cardiac index (CI). Myocardial contractility, assessed by several load-independent indexes, increased with dopexamine, as anticipated with an inotropic drug, but did not alter with SNP. Arterial compliance, a measure of the distensibility of large conduit arteries, was increased by SNP but not by dopexamine. Arterial wave reflection was increased by dopexamine, especially at high doses, but reduced by SNP. Increased arterial compliance and reduced wave reflection reduce LV afterload. SNP reduced preload, whereas dopexamine had no effect on this aspect of ventricular function. Vasodilator drugs and those which combine vasodilator and inotropy increase cardiac output (CO) and reduce SVR. Therapy with inotropic vasodilators has no effect on preload and does not reduce the dynamic components of ventricular afterload, although it does reduce its static components. These effects are dose dependent; there is less perturbation of afterload at lower doses. In contrast, vasodilator therapy reduces preload and both static and dynamic parts of afterload.


Sujet(s)
Maladie coronarienne/physiopathologie , Dopamine/analogues et dérivés , Hémodynamique/effets des médicaments et des substances chimiques , Nitroprussiate/pharmacologie , Vasodilatateurs/pharmacologie , Dysfonction ventriculaire gauche/physiopathologie , Dopamine/pharmacologie , Relation dose-effet des médicaments , Métabolisme énergétique/effets des médicaments et des substances chimiques , Humains , Contraction myocardique/effets des médicaments et des substances chimiques
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE
...